Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 40 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1984 adjusted for splits and dividends. The latest closing stock price for Amgen as of December 05, 2024 is 274.33.
  • The all-time high Amgen stock closing price was 334.68 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 26.4% above the current share price.
  • The Amgen 52-week low stock price is 257.80, which is 6% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 303.88.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 300.4897 288.6321 334.6787 256.9971 274.3300 -1.86%
2023 238.7464 245.4195 279.9651 204.6739 279.5380 13.47%
2022 227.8373 206.1250 272.3905 201.1028 246.3481 20.43%
2021 207.0438 199.9116 230.2700 180.8379 204.5610 0.87%
2020 201.3895 206.0918 227.0981 157.5493 202.7869 -2.00%
2019 166.4089 160.9980 208.7527 141.7032 206.9244 26.70%
2018 155.7230 144.3358 174.7151 136.4022 163.3219 15.17%
2017 137.4316 119.5855 154.7103 119.5855 141.8079 22.25%
2016 122.2495 122.3862 138.3875 106.5526 115.9995 -7.55%
2015 121.0427 121.1324 135.1484 101.6806 125.4702 3.97%
2014 98.4786 86.0700 130.0342 82.7566 120.6779 42.32%
2013 76.6343 65.0552 87.8540 59.8960 84.7952 34.80%
2012 55.2726 45.9084 65.7995 45.6578 62.9025 36.80%
2011 39.8237 39.3678 46.3595 34.2086 45.9800 18.18%
2010 39.5104 40.9024 43.3294 35.6897 38.9072 -2.95%
2009 38.9180 41.8057 45.6468 31.9691 40.0907 -2.04%
2008 36.2434 33.0250 46.6957 28.3264 40.9270 24.35%
2007 41.0506 48.4745 53.7543 32.9116 32.9116 -32.02%
2006 50.0648 56.9505 56.9505 45.2996 48.4107 -13.38%
2005 49.5726 45.5547 61.0680 40.5372 55.8874 22.93%
2004 41.7423 44.1869 46.9367 37.3481 45.4626 3.82%
2003 43.5411 34.9527 50.6998 34.6409 43.7901 27.82%
2002 35.0036 39.9702 44.2791 22.0191 34.2582 -14.35%
2001 44.1617 44.5625 52.5778 36.5047 39.9986 -11.73%
2000 46.3991 44.6051 55.2780 36.3630 45.3138 6.46%
1999 26.2991 19.0284 45.9799 18.5606 42.5640 129.89%
1998 11.8396 9.5567 18.5854 8.3502 18.5146 93.05%
1997 9.8741 9.6788 12.1151 8.1500 9.5904 -0.46%
1996 10.3467 10.3202 11.5160 9.1243 9.6345 -8.42%
1995 7.2216 5.1601 10.5204 5.0051 10.5204 101.29%
1994 4.2892 4.3513 5.2602 3.1324 5.2265 19.19%
1993 3.7250 6.2559 6.2674 2.7904 4.3850 -29.91%
1992 5.7129 6.6217 6.8875 4.4292 6.2559 -6.77%
1991 4.0021 1.8824 6.7103 1.7053 6.7103 265.07%
1990 1.1665 0.7604 1.8712 0.6607 1.8381 154.09%
1989 0.6474 0.4725 0.8858 0.4705 0.7234 45.17%
1988 0.4515 0.4761 0.5278 0.3802 0.4983 8.87%
1987 0.4760 0.3489 0.6570 0.2399 0.4577 40.92%
1986 0.2986 0.1863 0.4190 0.1846 0.3248 62.97%
1985 0.1133 0.0701 0.2141 0.0682 0.1993 170.05%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $146.521B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $120.433B 50.75
Vertex Pharmaceuticals (VRTX) United States $119.004B 0.00
Gilead Sciences (GILD) United States $114.818B 20.80
CSL (CSLLY) Australia $86.778B 0.00
Regeneron Pharmaceuticals (REGN) United States $85.494B 19.46
GSK (GSK) United Kingdom $71.648B 8.29
Argenex SE (ARGX) Netherlands $37.616B 0.00
Alnylam Pharmaceuticals (ALNY) United States $33.053B 0.00
BioNTech SE (BNTX) Germany $28.936B 0.00
Biogen (BIIB) United States $22.992B 9.87
Illumina (ILMN) United States $22.377B 81.56
BeiGene (BGNE) Cayman Islands $20.034B 0.00
Moderna (MRNA) United States $17.101B 0.00
Incyte (INCY) United States $14.626B 0.00
Genmab (GMAB) Denmark $14.433B 21.17
Insmed (INSM) United States $13.489B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.720B 29.53
Sarepta Therapeutics (SRPT) United States $12.243B 110.49
Bio-Techne Corp (TECH) United States $11.839B 45.71
Vaxcyte (PCVX) United States $11.630B 0.00
Exact Sciences (EXAS) United States $11.560B 0.00
Exelixis (EXEL) United States $10.229B 23.26
QIAGEN (QGEN) Netherlands $9.909B 20.39
Bio-Rad Laboratories (BIO.B) United States $9.437B 32.07
Roivant Sciences (ROIV) United Kingdom $8.997B 0.00
Intra-Cellular Therapies (ITCI) United States $8.964B 0.00
Repligen (RGEN) United States $8.359B 108.90
Revolution Medicines (RVMD) United States $8.086B 0.00
Ascendis Pharma (ASND) Denmark $8.065B 0.00
Legend Biotech (LEGN) United States $7.587B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.411B 7.25
Nuvalent (NUVL) United States $6.701B 0.00
Halozyme Therapeutics (HALO) United States $6.158B 13.91
Blueprint Medicines (BPMC) United States $6.097B 0.00
Cytokinetics (CYTK) United States $6.014B 0.00
Viking Therapeutics (VKTX) United States $5.661B 0.00
Telix Pharmaceuticals (TLX) Australia $5.590B 0.00
Krystal Biotech (KRYS) United States $5.328B 88.21
TG Therapeutics (TGTX) United States $5.282B 0.00
Alkermes (ALKS) Ireland $5.090B 17.10
Axsome Therapeutics (AXSM) United States $4.851B 0.00
ADMA Biologics Inc (ADMA) United States $4.685B 49.55
Arcellx (ACLX) United States $4.572B 0.00
Avidity Biosciences (RNA) United States $4.566B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.560B 0.00
Guardant Health (GH) United States $4.555B 0.00
Biohaven (BHVN) United States $4.530B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.467B 0.00
Immunovant (IMVT) United States $4.201B 0.00
Apellis Pharmaceuticals (APLS) United States $4.166B 0.00
Scholar Rock Holding (SRRK) United States $4.081B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.619B 0.00
Denali Therapeutics (DNLI) United States $3.582B 0.00
Agios Pharmaceuticals (AGIO) United States $3.515B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.471B 0.00
ImmunityBio (IBRX) United States $3.456B 0.00
Janux Therapeutics (JANX) United States $3.411B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.290B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.257B 0.00
Twist Bioscience (TWST) United States $3.128B 0.00
SpringWorks Therapeutics (SWTX) United States $3.092B 0.00
Edgewise Therapeutics (EWTX) United States $3.086B 0.00
Vera Therapeutics (VERA) United States $3.069B 0.00
Merus (MRUS) Netherlands $3.057B 0.00
Zai Lab (ZLAB) China $3.038B 0.00
NovoCure (NVCR) Jersey $3.025B 0.00
Kymera Therapeutics (KYMR) United States $3.023B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.974B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.938B 0.00
Amicus Therapeutics (FOLD) United States $2.907B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.875B 22.15
Keros Therapeutics (KROS) United States $2.836B 0.00
Vericel (VCEL) United States $2.782B 939.50
Iovance Biotherapeutics (IOVA) United States $2.752B 0.00
Protagonist Therapeutics (PTGX) United States $2.507B 15.81
IDEAYA Biosciences (IDYA) United States $2.402B 0.00
Geron (GERN) United States $2.376B 0.00
Ligand Pharmaceuticals (LGND) United States $2.359B 58.88
CG Oncology (CGON) United States $2.339B 0.00
WAVE Life Sciences (WVE) Singapore $2.329B 0.00
NeoGenomics (NEO) United States $2.280B 0.00
Belite Bio (BLTE) United States $2.277B 0.00
Apogee Therapeutics (APGE) United States $2.250B 0.00
Beam Therapeutics (BEAM) United States $2.212B 0.00
Akero Therapeutics (AKRO) United States $2.171B 0.00
Bavarian Nordic (BVNRY) Denmark $2.166B 13.27
Mirum Pharmaceuticals (MIRM) United States $2.144B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.980B 0.00
Fortrea Holdings (FTRE) United States $1.944B 61.91
Disc Medicine (IRON) United States $1.929B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.925B 16.00
Structure Therapeutics (GPCR) United States $1.910B 0.00
MannKind (MNKD) United States $1.875B 48.57
Arvinas (ARVN) United States $1.781B 0.00
Galapagos (GLPG) Belgium $1.779B 0.00
Celldex Therapeutics (CLDX) United States $1.776B 0.00
Certara (CERT) United States $1.747B 49.32
Dynavax Technologies (DVAX) United States $1.689B 98.85
Neumora Therapeutics (NMRA) United States $1.662B 0.00
Arcus Biosciences (RCUS) United States $1.582B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.577B 0.00
Viridian Therapeutics (VRDN) United States $1.562B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.553B 0.00
Nurix Therapeutics (NRIX) United States $1.514B 0.00
Travere Therapeutics (TVTX) United States $1.500B 0.00
Intellia Therapeutics (NTLA) United States $1.499B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.452B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.451B 0.00
Novavax (NVAX) United States $1.432B 0.00
MiMedx (MDXG) United States $1.422B 37.23
Spyre Therapeutics (SYRE) United States $1.393B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.387B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.377B 0.00
Myriad Genetics (MYGN) United States $1.377B 0.00
Praxis Precision Medicines (PRAX) United States $1.302B 0.00
Upstream Bio (UPB) United States $1.278B 0.00
Mesoblast (MESO) Australia $1.267B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.266B 0.00
ANI Pharmaceuticals (ANIP) United States $1.198B 16.32
Vir Biotechnology (VIR) United States $1.150B 0.00
Bicara Therapeutics (BCAX) United States $1.148B 0.00
Septerna (SEPN) United States $1.143B 0.00
Gyre Therapeutics (GYRE) United States $1.076B 0.00
LENZ Therapeutics (LENZ) United States $1.016B 0.00
ArriVent BioPharma (AVBP) United States $0.986B 0.00
Cogent Biosciences (COGT) United States $0.982B 0.00
Zymeworks (ZYME) United States $0.982B 0.00
Nuvation Bio (NUVB) United States $0.959B 0.00
Immatics (IMTX) Germany $0.937B 0.00
Liquidia Technologies (LQDA) United States $0.932B 0.00
Adaptive Biotechnologies (ADPT) United States $0.925B 0.00
Poseida Therapeutics (PSTX) United States $0.912B 0.00
Replimune (REPL) United States $0.895B 0.00
Pliant Therapeutics (PLRX) United States $0.894B 0.00
Pacira BioSciences (PCRX) United States $0.890B 8.38
AbCellera Biologics (ABCL) Canada $0.886B 0.00
Castle Biosciences (CSTL) United States $0.874B 155.95
Immunome (IMNM) United States $0.857B 0.00
Erasca (ERAS) United States $0.857B 0.00
89BIO (ETNB) United States $0.856B 0.00
CARGO Therapeutics (CRGX) United States $0.850B 0.00
Cytek Biosciences (CTKB) United States $0.833B 0.00
Kura Oncology (KURA) United States $0.830B 0.00
Entrada Therapeutics (TRDA) United States $0.808B 13.58
Tyra Biosciences (TYRA) United States $0.796B 0.00
Avid Bioservices (CDMO) United States $0.783B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.782B 0.00
Cullinan Therapeutics (CGEM) United States $0.760B 0.00
Tectonic Therapeutic (TECX) United States $0.759B 0.00
Prothena (PRTA) Ireland $0.756B 0.00
AnaptysBio (ANAB) United States $0.755B 0.00
Rapport Therapeutics (RAPP) United States $0.748B 0.00
MBX Biosciences (MBX) United States $0.741B 0.00
GRAIL (GRAL) United States $0.726B 0.00
Dianthus Therapeutics (DNTH) United States $0.722B 0.00
BioAge Labs (BIOA) United States $0.720B 0.00
Stoke Therapeutics (STOK) United States $0.703B 0.00
Oric Pharmaceuticals (ORIC) United States $0.699B 0.00
Arbutus Biopharma (ABUS) United States $0.697B 0.00
CureVac (CVAC) Germany $0.694B 5.64
Anavex Life Sciences (AVXL) United States $0.690B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.670B 0.00
Oculis Holding AG (OCS) Switzerland $0.665B 0.00
Mineralys Therapeutics (MLYS) United States $0.657B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Cartesian Therapeutics (RNAC) United States $0.639B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.615B 0.00
IGM Biosciences (IGMS) United States $0.613B 0.00
Humacyte (HUMA) United States $0.608B 0.00
Olema Pharmaceuticals (OLMA) United States $0.599B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.594B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.585B 0.00
Astria Therapeutics (ATXS) United States $0.584B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.578B 0.00
CorMedix Inc (CRMD) United States $0.576B 0.00
Abivax SA (ABVX) France $0.558B 0.00
Terns Pharmaceuticals (TERN) United States $0.556B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.546B 0.00
Annexon (ANNX) United States $0.544B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.531B 0.00
PureTech Health (PRTC) United States $0.529B 0.00
Third Harmonic Bio (THRD) United States $0.527B 0.00
Pharming Group (PHAR) Netherlands $0.524B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.517B 0.00
Sana Biotechnology (SANA) United States $0.514B 0.00
ChromaDex (CDXC) United States $0.513B 672.00
Celcuity (CELC) United States $0.488B 0.00
Emergent Biosolutions (EBS) United States $0.488B 0.00
MeiraGTx Holdings (MGTX) United States $0.480B 0.00
REGENXBIO (RGNX) United States $0.475B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.472B 0.00
Allogene Therapeutics (ALLO) United States $0.459B 0.00
Zenas BioPharma (ZBIO) United States $0.453B 0.00
Aura Biosciences (AURA) United States $0.448B 0.00
Prime Medicine (PRME) United States $0.429B 0.00
ACELYRIN, INC (SLRN) United States $0.426B 0.00
Alpha Teknova (TKNO) United States $0.426B 0.00
Alumis (ALMS) United States $0.425B 0.00
GH Research (GHRS) Ireland $0.422B 0.00
Sangamo Therapeutics (SGMO) United States $0.419B 0.00
Kodiak Sciences (KOD) United States $0.412B 0.00
Revance Therapeutics (RVNC) United States $0.401B 0.00
Codexis (CDXS) United States $0.385B 0.00
EnGene Holdings (ENGN) Canada $0.382B 0.00
MaxCyte (MXCT) United States $0.380B 0.00
Contineum Therapeutics (CTNM) United States $0.379B 0.00
Foghorn Therapeutics (FHTX) United States $0.365B 0.00
Tango Therapeutics (TNGX) United States $0.364B 0.00
UniQure (QURE) Netherlands $0.363B 0.00
Design Therapeutics (DSGN) United States $0.363B 0.00
Northwest Biotherapeutics (NWBO) United States $0.361B 0.00
Absci (ABSI) United States $0.357B 0.00
XOMA Royalty (XOMA) United States $0.355B 0.00
Neurogene (NGNE) United States $0.352B 0.00
Voyager Therapeutics (VYGR) United States $0.352B 9.08
Kamada (KMDA) Israel $0.349B 21.71
Sage Therapeutics (SAGE) United States $0.343B 0.00
Jasper Therapeutics (JSPR) United States $0.337B 0.00
Eton Pharmaceuticals (ETON) United States $0.331B 0.00
Q32 Bio (QTTB) United States $0.316B 0.00
Mersana Therapeutics (MRSN) United States $0.313B 0.00
C4 Therapeutics (CCCC) United States $0.312B 0.00
AC Immune (ACIU) Switzerland $0.312B 0.00
Prima BioMed (IMMP) Australia $0.304B 0.00
ITeos Therapeutics (ITOS) United States $0.304B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.303B 0.00
Fate Therapeutics (FATE) United States $0.302B 0.00
Rezolute (RZLT) United States $0.300B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.291B 0.00
Urogen Pharma (URGN) United States $0.288B 0.00
Artiva Biotherapeutics (ARTV) United States $0.287B 0.00
Tenaya Therapeutics (TNYA) United States $0.284B 0.00
TuHURA Biosciences (HURA) United States $0.282B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
ATyr Pharma (ATYR) United States $0.282B 0.00
Renovaro (RENB) United States $0.281B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.275B 0.00
Nautilus Biotechnology (NAUT) United States $0.269B 0.00
Lifecore Biomedical (LFCR) United States $0.263B 0.00
Abeona Therapeutics (ABEO) United States $0.262B 0.00
Benitec Biopharma (BNTC) United States $0.261B 0.00
BioStem Technologies (BSEM) $0.256B 22.62
Anika Therapeutics (ANIK) United States $0.256B 0.00
Ocugen (OCGN) United States $0.253B 0.00
Verastem (VSTM) United States $0.251B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.249B 0.00
Atea Pharmaceuticals (AVIR) United States $0.248B 0.00
TScan Therapeutics (TCRX) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.234B 0.00
DiaMedica Therapeutics (DMAC) United States $0.231B 0.00
Molecular Partners AG (MOLN) Switzerland $0.231B 0.00
Compass Therapeutics (CMPX) United States $0.228B 0.00
Precigen (PGEN) United States $0.227B 0.00
Inhibrx Biosciences (INBX) United States $0.227B 0.00
Biomea Fusion (BMEA) United States $0.221B 0.00
Ventyx Biosciences (VTYX) United States $0.221B 0.00
Opthea (OPT) Australia $0.217B 0.00
Fulcrum Therapeutics (FULC) United States $0.215B 0.00
Trevi Therapeutics (TRVI) United States $0.212B 0.00
Alector (ALEC) United States $0.212B 0.00
Checkpoint Therapeutics (CKPT) United States $0.206B 0.00
Climb Bio (CLYM) United States $0.203B 0.00
Solid Biosciences (SLDB) United States $0.202B 0.00
Amarin (AMRN) Ireland $0.198B 0.00
Semper Paratus Acquisition (TVGN) United States $0.198B 0.00
Kyverna Therapeutics (KYTX) United States $0.196B 0.00
Coherus BioSciences (CHRS) United States $0.196B 0.00
XBiotech (XBIT) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Caribou Biosciences (CRBU) United States $0.193B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.191B 0.00
Zura Bio (ZURA) United States $0.188B 0.00
PepGen (PEPG) United States $0.186B 0.00
2seventy Bio (TSVT) United States $0.182B 0.00
Nkarta (NKTX) United States $0.182B 0.00
Instil Bio (TIL) United States $0.181B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
Editas Medicine (EDIT) United States $0.177B 0.00
Actuate Therapeutics (ACTU) United States $0.175B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.174B 0.00
ScPharmaceuticals (SCPH) United States $0.173B 0.00
Bright Minds Biosciences (DRUG) United States $0.171B 0.00
Gossamer Bio (GOSS) United States $0.171B 0.00
Adherex Technologies (FENC) United States $0.169B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.168B 0.00
Cidara Therapeutics (CDTX) United States $0.167B 0.00
Candel Therapeutics (CADL) United States $0.167B 0.00
Inozyme Pharma (INZY) United States $0.165B 0.00
Cabaletta Bio (CABA) United States $0.161B 0.00
CAMP4 Therapeutics (CAMP) United States $0.157B 0.00
Sagimet Biosciences (SGMT) United States $0.156B 0.00
InflaRx (IFRX) Germany $0.154B 0.00
Puma Biotechnology (PBYI) United States $0.153B 6.50
Elutia (ELUT) United States $0.152B 0.00
Applied Therapeutics (APLT) United States $0.149B 0.00
Compugen (CGEN) Israel $0.147B 82.50
Seer (SEER) United States $0.146B 0.00
Seres Therapeutics (MCRB) United States $0.141B 0.00
Inventiva S.A (IVA) France $0.139B 0.00
Black Diamond Therapeutics (BDTX) United States $0.136B 0.00
Repare Therapeutics (RPTX) Canada $0.134B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.130B 0.00
Leap Therapeutics (LPTX) United States $0.125B 0.00
Scilex Holding (SCLX) United States $0.124B 0.00
Adverum Biotechnologies (ADVM) United States $0.123B 0.00
Innate Pharma S.A (IPHA) France $0.119B 0.00
Cardiff Oncology (CRDF) United States $0.118B 0.00
TELA Bio (TELA) United States $0.117B 0.00
Immunic (IMUX) United States $0.115B 0.00
MediciNova (MNOV) United States $0.115B 0.00
Monopar Therapeutics (MNPR) United States $0.113B 0.00
Skye Bioscience (SKYE) United States $0.113B 0.00
Cellectis S.A (CLLS) France $0.111B 0.00
Rani Therapeutics Holdings (RANI) United States $0.111B 0.00
Inovio Pharmaceuticals (INO) United States $0.109B 0.00
INmune Bio (INMB) United States $0.109B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.106B 0.00
23andMe Holding (ME) United States $0.106B 0.00
Alto Neuroscience (ANRO) United States $0.105B 0.00
Akoya Biosciences (AKYA) United States $0.105B 0.00
Aligos Therapeutics (ALGS) United States $0.103B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
HilleVax (HLVX) United States $0.100B 0.00
BioHarvest Sciences (BHST) Canada $0.099B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
Allakos (ALLK) United States $0.098B 0.00
Genenta Science S.p.A (GNTA) Italy $0.096B 0.00
Vigil Neuroscience (VIGL) United States $0.095B 0.00
Nuvectis Pharma (NVCT) United States $0.094B 0.00
Genelux (GNLX) United States $0.094B 0.00
Quince Therapeutics (QNCX) United States $0.092B 0.00
CytomX Therapeutics (CTMX) United States $0.092B 6.94
Adagene (ADAG) China $0.091B 0.00
Bluebird Bio (BLUE) United States $0.089B 0.00
Generation Bio (GBIO) United States $0.087B 0.00
Adicet Bio (ACET) United States $0.087B 0.00
FibroBiologics (FBLG) United States $0.086B 0.00
ALX Oncology Holdings (ALXO) United States $0.085B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.085B 0.00
Agenus (AGEN) United States $0.084B 0.00
I-Mab (IMAB) China $0.083B 0.00
Annovis Bio (ANVS) United States $0.083B 0.00
Invizyne Technologies (IZTC) United States $0.083B 0.00
Ovid Therapeutics (OVID) United States $0.082B 0.00
PDS Biotechnology (PDSB) United States $0.081B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Werewolf Therapeutics (HOWL) United States $0.080B 0.00
BioAtla (BCAB) United States $0.079B 0.00
Abpro Holdings (ABP) United States $0.079B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Adlai Nortye (ANL) Cayman Islands $0.077B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.077B 0.00
DBV Technologies S.A (DBVT) France $0.075B 0.00
Atara Biotherapeutics (ATRA) United States $0.075B 0.00
Chimerix (CMRX) United States $0.075B 0.00
CervoMed (CRVO) United States $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.072B 0.00
Entera Bio (ENTX) Israel $0.072B 0.00
Immix Biopharma (IMMX) United States $0.070B 0.00
Invivyd (IVVD) United States $0.070B 0.00
Cue Biopharma (CUE) United States $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
X4 Pharmaceuticals (XFOR) United States $0.068B 0.00
Oncolytics Biotech (ONCY) Canada $0.068B 0.00
Immuneering (IMRX) United States $0.068B 0.00
BeyondSpring (BYSI) United States $0.066B 0.00
Theratechnologies (THTX) Canada $0.065B 0.00
Spero Therapeutics (SPRO) United States $0.064B 16.71
Exicure (XCUR) United States $0.063B 0.00
Boundless Bio (BOLD) United States $0.063B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
BGM Group (BGM) China $0.061B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Aadi Bioscience (AADI) United States $0.060B 0.00
VTv Therapeutics (VTVT) United States $0.057B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
Vor Biopharma (VOR) $0.056B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.055B 0.00
Omega Therapeutics (OMGA) United States $0.053B 0.00
Elicio Therapeutics (ELTX) United States $0.052B 0.00
Celularity (CELU) United States $0.052B 0.00
Kezar Life Sciences (KZR) United States $0.050B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
Passage Bio (PASG) United States $0.048B 0.00
Aileron Therapeutics (ALRN) United States $0.048B 0.00
OnKure Therapeutics (OKUR) United States $0.047B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.047B 0.00
Dyadic (DYAI) United States $0.047B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.046B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Precision BioSciences (DTIL) United States $0.045B 0.00
Rallybio (RLYB) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.044B 0.00
AN2 Therapeutics (ANTX) United States $0.043B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Lexaria Bioscience (LEXX) Canada $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Forte Biosciences (FBRX) United States $0.041B 0.00
CalciMedica (CALC) United States $0.039B 0.00
Intensity Therapeutics (INTS) United States $0.038B 0.00
Affimed (AFMD) Germany $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Rapt Therapeutics (RAPT) United States $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Oncobiologics (OTLK) United States $0.036B 0.00
Elevation Oncology (ELEV) United States $0.035B 0.00
Beyond Air (XAIR) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
BRIACELL THERAP (BCTX) Canada $0.035B 0.00
Alpha Cognition (ACOG) Canada $0.034B 0.00
RenovoRx (RNXT) United States $0.034B 0.00
Curis (CRIS) United States $0.033B 0.00
Medicus Pharma (MDCX) Canada $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
NextCure (NXTC) United States $0.032B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Longeveron (LGVN) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
HOOKIPA Pharma (HOOK) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
MiNK Therapeutics (INKT) United States $0.027B 0.00
Equillium (EQ) United States $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
LakeShore Biopharma (LSB) China $0.026B 0.00
Senti Biosciences (SNTI) United States $0.025B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Ocean Biomedical (OCEA) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
GeoVax Labs (GOVX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
IN8bio (INAB) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
Spruce Biosciences (SPRB) United States $0.021B 0.00
Tenax Therapeutics (TENX) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
MetaVia (MTVA) United States $0.020B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
Gelteq (GELS) Australia $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
BioAffinity Technologies (BIAF) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
NKGen Biotech (NKGN) United States $0.016B 0.00
HCW Biologics (HCWB) United States $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Ensysce Biosciences (ENSC) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Apollomics (APLM) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Evaxion Biotech (EVAX) Denmark $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Biora Therapeutics (BIOR) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Elevai Labs (ELAB) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Entero Therapeutics (ENTO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Palisade Bio (PALI) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00